- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05149521
Recommendations for a Radiotherapy Comfort Intervention Package Radiotherapy
A Consensus Study Using Nominal Group Technique to Develop Recommendations for a Comfort Intervention Package in Radiotherapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Design
The aim of this study is to develop a radiotherapy comfort intervention package with patients and therapeutic radiographers.
The objectives are to:
Objective 1 - Identify and prioritise intervention components for inclusion in recommendations for a radiotherapy comfort intervention package.
Objective 2 - Determine the feasibility of delivering the component of the radiotherapy comfort intervention package.
Modified nominal group technique (NGT) will employed to develop recommendations for a comfort intervention package in radiotherapy in a consensus study with patients and therapeutic radiographers. This study follows earlier phases of the COMFORT study which included a systematic literature review of comfort interventions applicable to radiotherapy and qualitative interviews exploring comfort management in radiotherapy.
Study Participants
Patients
The inclusion criteria are: 1) diagnosed with a malignancy; 2) aged over 18 years owing to different treatment options for children and young adults; 3) recently referred for radiotherapy, currently receiving treatment or had had radiotherapy within the previous 3 months; 4) treatment delivery time exceeding 10 minutes (the time the patient is immobilised on the radiotherapy couch).
Therapeutic radiographers
The inclusion criteria are: 1) practicing radiographers; 2) administering radiotherapy with treatment delivery times exceeding 10 minutes per radiotherapy treatment session (the time the patient is immobilised on the radiotherapy couch).
The consensus study will be conducted by video conference.
Planned Size of Sample (if applicable)
6-12 participants (4-9 Patients and 2-3 Therapeutic radiographers)
Follow up duration (if applicable)
Follow up is not planned.
Planned Study Period
6 months
Research Question/Aim(s)
The aim of this study is to develop recommendations for a radiotherapy comfort intervention with patients and therapeutic radiographers.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Simon Goldsworthy, MSc
- Phone Number: 01823344250
- Email: simon.goldsworthy@somersetft.nhs.uk
Study Contact Backup
- Name: Tamlyn Russel, BSc
- Phone Number: 01823343369
- Email: tamlyn.russel@somersetft.nhs.uk
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients and therapeutic radiographers who previously participated in COMFORT study interviews
Exclusion Criteria:
Patients and therapeutic radiographers who did not participate in COMFORT study interviews
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patients who have received radiotherapy
This is a consensus study with no interventions Patients who previously participated in COMFORT study interviews (NCT03984435)
|
None - this is a consensus group study to develop an intervention
|
Therapeutic radiographers who deliver radiotherapy
This is a consensus study with no interventions Therapeutic radiographers who previously participated in COMFORT study interviews (NCT03984435)
|
None - this is a consensus group study to develop an intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Prioritisation of comfort interventions applicable to radiotherapy
Time Frame: 1 month
|
Consensus among patients and therapeutic radiographers using nominal group technique to achieve priority of comfort interventions
|
1 month
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Simon Goldsworthy, MSc, Somerset NHS Foundation Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HAS..21.10.024
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
The data will be the property of the Chief Investigator at the University of the West of England who is the data controller.
A full data management plan can be found in the UWE research repository at the following URL:
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oncology
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
State University of New York at BuffaloRecruitingMedical Oncology | Integrative Oncology | Medical Nutrition TherapyUnited States
-
MaineHealthTufts Medical CenterRecruitingOncology | Prehabilitation | Surgical OncologyUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Royal Marsden NHS Foundation TrustRecruiting
-
GuerbetRecruitingOncologyAustria, France, Switzerland
-
Centre Hospitalier Regional de HuyCompleted
Clinical Trials on None - this is a consensus group study to develop an intervention
-
Beijing Friendship HospitalUnknownFrail Elderly Syndrome | ACS | Elderly PatientChina
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI); Oxford University Hospitals...Active, not recruitingHypertrophic CardiomyopathyUnited States, Canada, Germany, United Kingdom, Netherlands, Italy
-
Instituto de Seguridad y Servicios Sociales de...CompletedCholedocholithiasis
-
University of New MexicoUniversity of Texas at Austin; Albany Medical CollegeTerminatedUrinary Incontinence | Pelvic Organ Prolapse | Fecal Incontinence | Sexual Function DisturbancesUnited States
-
University of ZurichSwiss Tropical & Public Health InstituteCompletedRisk Behavior | Travel Health | Mobile Health Technology (mHealth) | Elderly Travelers | Chronic Diseased TravelersSwitzerland
-
Stanford UniversityUniversity of Southern CaliforniaActive, not recruitingCommunicationUnited States
-
University of GlasgowCompletedCardiovascular Diseases | Cancer | All-cause Mortality
-
Sir Run Run Shaw HospitalUniversity of BirminghamUnknown
-
Satellite HealthcareCompleted